Kozhuharov, Nikola
Ng, Leong
Wussler, Desiree
Strebel, Ivo
Sabti, Zaid
Hartmann, Oliver
Eltayeb, Mohamed
Squire, Iain
Nowak, Albina
Rieger, Max
Martin, Jasmin
Michou, Eleni
Stefanelli, Sabrina
Puelacher, Christian
Shrestha, Samyut
Belkin, Maria
Zimmermann, Tobias
Lopez-Ayala, Pedro
Struck, Joachim
Bergmann, Andreas
Mebazaa, Alexandre
Blet, Alice
Gualandro, Danielle Menosi
Breidthardt, Tobias
Mueller, Christian http://orcid.org/0000-0002-1120-6405
Funding for this research was provided by:
European Union
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Schweizerische Herzstiftung
Cardiovascular Research Foundation Basel
University of Basel
University Hospital Basel
Critical Diagnostics
Abbott
BRAHMS
Roche
Singulex
Universität Basel
Article History
Received: 21 April 2021
Accepted: 7 July 2021
First Online: 23 July 2021
Declarations
:
: Christian Mueller, as principal investigator, was supported by grants from the Swiss National Science Foundation (PP00B-102853), the Swiss Heart Foundation, the University of Basel, Abbott, ALERE, BRAHMS, and Pronota. In addition, Christian Mueller received lecture fees from Abbott, ALERE, BRAHMS, Novartis, and Roche. Nikola Kozhuharov was supported by grants from the Swiss National Science Foundation (P400PM-194477), Gottfried und Julia Bangerter-Rhyner-Stiftung, and the European Society of Cardiology. Iain Squire reports grants and personal fees from NOVARTIS, grants and personal fees from VIFOR, grants from BOEHRINGER INGELHEIM, grants from ASTRA ZENECA, grants from MERCK, outside the submitted work. Andreas Bergmann is the director of Sphingotec GmbH which is the manufacturer of Sphingotest bio-ADM diagnostic test. Joachim Struck and Oliver Hartmann are employed by Sphingotec GmbH. Christian Puelacher reports grants from Roche Diagnostics, outside the submitted work. Dr. Mebazaa reports personal fees from Orion, grants and personal fees from Roche, personal fees from Servier, personal fees from Otsuka, personal fees from Philips, grants and personal fees from Adrenomed, personal fees from Neuro Tronik, grants and personal fees from 4TEEN4, personal fees from Sanofi, outside the submitted work; and Alexandre Mebazaa owns shares of S-Form Pharma. Dr. Breidthardt has received research grants from the Swiss National Science Foundation (PASMP3-134362), the University Hospital Basel, the Department of Internal Medicine, University Hospital Basel, Abbott, and Roche as well as speaker honoraria from Roche. All the other authors declare that they have no conflict of interest with this study.
: This study complied with the Declaration of Helsinki and ethics approval was granted from the respective research ethics committees.
: All the patients provided written informed consent.
: All the authors have read and approved the manuscript.